Eric A. Murphy
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Cell Adhesion Molecules Research 3
-
- Angiogenesis and VEGF in Cancer 4
- Melanoma and MAPK Pathways 2
- Protein Kinase Regulation and GTPase Signaling 1
- TGF-β signaling in diseases 1
- Co-authors
- David A. Cheresh (10 shared papers)Sara M. Weis (5 shared papers)David J. Shields (6 shared papers)Bharat Kumar Majeti (4 shared papers)Lisette M. Acevedo (4 shared papers)Lea Scheppke (3 shared papers)Leo A. Barnes (3 shared papers)Wolfgang Wrasidlo (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Nature Medicine (2 papers)Journal of Medicinal Chemistry (2 papers)Blood (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Eric A. Murphy
15 papers receiving 2k citations
Peers
Comparison fields: 5 of 84
- Biomaterials 341
- Cancer Research 272
- Molecular Biology 774
- Immunology and Allergy 58
- Neurology 83
Countries citing papers authored by Eric A. Murphy
This map shows the geographic impact of Eric A. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Murphy more than expected).
Fields of papers citing papers by Eric A. Murphy
This network shows the impact of papers produced by Eric A. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Murphy. The network helps show where Eric A. Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric A. Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 538 | |
| 2 | 2010 | 443 | |
| 3 | 2008 | 414 | |
| 4 | 2011 | 124 | |
| 5 | 2016 | 109 | |
| 6 | 2009 | 78 | |
| 7 | 2011 | 74 | |
| 8 | 2009 | 59 | |
| 9 | 2011 | 55 | |
| 10 | 2010 | 54 | |
| 11 | 2012 | 35 | |
| 12 | 2024 | 16 | |
| 13 | 2024 | 10 | |
| 14 | 2009 | 3 | |
| 15 | 2026 | 1 |
About Eric A. Murphy
Eric A. Murphy is a scholar working on Immunology and Allergy, Molecular Biology, Biomaterials, Pulmonary and Respiratory Medicine and Cancer Research, having authored 15 papers that have together received 2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Melanoma and MAPK Pathways (2 papers), Synthesis and biological activity (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Biomaterials (341 citations), Cancer Research (272 citations), Molecular Biology (774 citations), Immunology and Allergy (58 citations) and Neurology (83 citations). Eric A. Murphy has collaborated with scholars based in United States. Frequent co-authors include David A. Cheresh, Sara M. Weis, David J. Shields, Bharat Kumar Majeti, Lisette M. Acevedo, Lea Scheppke, Leo A. Barnes, Wolfgang Wrasidlo, Milan Makale and Joshua I. Greenberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine, Journal of Medicinal Chemistry, Blood and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.